Skip to main content

Antidepressant Recall

May 19, 2016

The U.S. Food and Drug Administration (FDA) announced the recall of venlafaxine 75 mg tablets.

What prompted the Class III recall? A labeling mix-up. The medication was manufactured by Teva and repackaged by Bryant Ranch Prepack, who received the extended-release tablets, but they then labeled them as immediate-release tablets, according to the FDA’s Enforcement Report.

The impacted lot is #94983, with an expiration of October 2017. The products were distributed nationwide.

Click here to read the report.


--Stephanie Vaccaro



1. U.S. Food and Drug Administration. Enforcement Report – Week of May 11, 2016. Accessed May 12, 2016.

Back to Top